A quantitative NMR protocol for the simultaneous analysis of atropine and obidoxime in parenteral injection devices

Journal of Pharmaceutical and Biomedical Analysis

Volumn 49, Issue 4, 2009, Pages 1092-1096

  Sharma, Radha ^a   Gupta, Pradeep K ^a   Mazumder, Avik ^a   Dubey, Devendra K ^a   Ganesan, Kumaran ^a   Vijayaraghavan, R ^a  

^a DEFENCE RESEARCH AND DEVELOPMENT ESTABLISHMENT   (India)

Author keywords

3 (Trimethylsilyl) 1 propane sulfonate hydrate; 1H NMR; Atropine sulfate; HPLC; Methyl 4 hydroxy benzoate; Obidoxime chloride

Indexed keywords

ATROPINE; OBIDOXIME;

ACCURACY; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DETERMINATION; INTERMETHOD COMPARISON; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; QUANTITATIVE ASSAY;

ALGORITHMS; ALKANESULFONIC ACIDS; ATROPINE; CHOLINESTERASE REACTIVATORS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; INFUSIONS, PARENTERAL; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR WEIGHT; MUSCARINIC ANTAGONISTS; OBIDOXIME CHLORIDE; PHARMACEUTICAL SOLUTIONS; REPRODUCIBILITY OF RESULTS; SPECTROPHOTOMETRY, ULTRAVIOLET; TRIMETHYLSILYL COMPOUNDS;

EID: 62749136939     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2009.01.035     Document Type: Article

References (23)

1. Nagao M., Takatori T., Matsuda Y., Nakajima M., Iwase H., and Iwadate K. Toxicol. Appl. Pharmacol. 144 (1997) 198-203
2. Okumura T., Hisaoka T., Yamada A., Naito T., Isonuma H., Okumura S., Miura K., Sakurada M., Maekawa H., Ishimatsu S., Takasu N., and Suzuki K. Toxicol. Appl. Pharmacol. 207 (2005) 471-476
3. Macilwain C. Nature 363 (1993) 3
4. Tu A.T. J. Mass Spectrom. Soc. Japan 44 (1996) 293-320
5. Riihimaki V., Kantolahti E., and Vaisakorpi R. In: Koskenvuo K. (Ed). Kenttalaakinta. Ensihoidon Perusteet (1993), Finnsh Defense Forces, Hameenlinna 494-500
6. Vijayaraghavan R., Jain N., Gautam A., Sharma M., Singh S., Kumar D., Singh R., Kumar P., Bhaskar A.S.B., Gupta A.K., and Jain S. J. Med. CBR Def. 5 (2007) 1-12
7. Kumar P., Vijayaraghavan R., Kumar D., Jain N., Swarnkar H.M., Waghmare C.K., Bhattacharya B.K., Sharma M., and Jain S. Curr. Trends Biotechnol. Pharm. 2 (2008) 251-259
8. Gosslin R.E., Hodge H.C., Smith R.P., and Gleason M.N. Clinical Toxicology of Commercial Products. 4th ed. (1976), Williams and Wilkins, Baltomore
9. Hobbiger F. In: Koelle G.B. (Ed). Handbuch der Experimentellen Pharmakologie (Cholinesterases and Anticholinesterases) vol. 15 (1963), Springer, Heidelberg 921-988
10. Puu G., Arturssun E., and Bucht G. Biochem. Pharmacol. 35 (1985) 1505-1510
11. Grasshoff C., Thiermann H., Gilssen T., Zilker T., and Szinicz L. J. Chromatogr. B 756 (2001) 203-208
12. Pahjola J., and Harpf M. J. Chromatogr. A 686 (1994) 350-354
13. Spohrer U., and Eyer P. J. Chromatogr. A 693 (1995) 55-61
14. Benschop H.P., Konings K.A.G., Kosses S.P., and Ligtense D.A. J. Chromatogr. 225 (1981) 107-114
15. Briggs C.L., and Simons K.J. J. Chromatogr. 257 (1983) 132-136
16. Brown N.D., Hall L.L., Sleeman H.K., Doctor B.P., and Demaree G.E. J. Chromatogr. 148 (1978) 453-457
17. Paddle B.M., and Dowling M.H. J. Chromatogr. 648 (1993) 373-380
18. Quinn T.J. Metrologia 34 (1997) 61-65
19. Malz F., and Jancke H. J. Pharm. Biomed. Anal. 38 (2005) 813-823
20. Holzgrabe U., Deubner R., Schollmayer C., and Waibel B. J. Pharm. Biomed. Anal. 38 (2005) 806-812
21. Bernd W.K., Diehl F., Malz U., and Holzgrabe. Spectrosc. Asia 3 4 (2007) 15-19
22. Holzgrabe U., Wawer I., and Diehl B. NMR Spectroscopy in Drug Development and Analysis (1999), Wiley-VCH Verlag GmbH, Weinheim
23. Maniara G., Rajamoorthy K., Rajan S., and Stockton G.W. Anal. Chem. 70 (1998) 4921-4928